Replimune Group, Inc. Vs. Spyre Therapeutics, Inc. Industry Stock Comparison

Sell

45

REPL
Replimune Group, Inc.

Last Price:

$8.40

Seasonality Move:

29.77%

Buy

63

SYRE
Spyre Therapeutics, Inc.

Last Price:

$47.58

Seasonality Move:

-1.09%

Sell

45

Replimune Group, Inc. (REPL) is a Sell

Is Replimune Group, Inc. a Buy, Sell or Hold?

The current Replimune Group, Inc. [REPL] share price is $8.41. The Score for REPL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
REPL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

63

Spyre Therapeutics, Inc. (SYRE) is a Buy

Is Spyre Therapeutics, Inc. a Buy, Sell or Hold?

The current Spyre Therapeutics, Inc. [SYRE] share price is $47.58. The Score for SYRE is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
SYRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

REPL Stock Price Chart

What is Replimune Group, Inc.'s stock price today?

The Replimune Group, Inc. share price today is $8.41

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REPL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics, Inc.'s stock price today?

The Spyre Therapeutics, Inc. share price today is $47.58

The current trend is moderately bullish and SYRE is experiencing slight buying pressure.

REPL Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.01	Buy
Relative Strength Index (14 RSI):	61.9	Buy
Chaikin Money Flow:	3008589	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(6.95 - 7.93)	Buy
Bollinger Bands (100):	(7.28 - 9.5)	Buy

SYRE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.39	Buy
Relative Strength Index (14 RSI):	60.73	Buy
Chaikin Money Flow:	101552	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(40.42 - 46.32)	Buy
Bollinger Bands (100):	(28.36 - 41.52)	Buy

REPL Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	7.52	Buy
20-day SMA:	7.48	Buy
50-day SMA:	7.58	Buy
200-day SMA:	7.6	Buy
8-day EMA:	7.62	Buy
20-day EMA:	7.51	Buy
50-day EMA:	7.68	Buy
200-day EMA:	8.12	Buy

SYRE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	46.88	Buy
20-day SMA:	43.85	Buy
50-day SMA:	39.64	Buy
200-day SMA:	26.25	Buy
8-day EMA:	46.92	Buy
20-day EMA:	44.54	Buy
50-day EMA:	40.51	Buy
200-day EMA:	30.19	Buy

Replimune Group, Inc. Earnings Growth & REPL Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.39 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.34 per share, and an increase next year of $1.15 per share.

Spyre Therapeutics, Inc. Earnings Growth & SYRE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.51 per share, a decrease this year of $0.72 per share, and a decrease next year of $0.16 per share.

Replimune Group, Inc. Technical Analysis

	Mar 20	Mar 23	Mar 24	Mar 25	Mar 26	Mar 27	Mar 30	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	23	24	25	26	27	30	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics, Inc. Technical Analysis

	Mar 20	Mar 23	Mar 24	Mar 25	Mar 26	Mar 27	Mar 30	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	23	24	25	26	27	30	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):